These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

414 related items for PubMed ID: 7724569

  • 21. Involvement of CB1 and CB2 receptors in the modulation of cholinergic neurotransmission in mouse gastric preparations.
    Mulè F, Amato A, Baldassano S, Serio R.
    Pharmacol Res; 2007 Sep; 56(3):185-92. PubMed ID: 17656103
    [Abstract] [Full Text] [Related]

  • 22. Evidence for a modulatory role of cannabinoids on the excitatory NANC neurotransmission in mouse colon.
    Mulè F, Amato A, Baldassano S, Serio R.
    Pharmacol Res; 2007 Aug; 56(2):132-9. PubMed ID: 17574859
    [Abstract] [Full Text] [Related]

  • 23. A peripheral mechanism for CB1 cannabinoid receptor-dependent modulation of feeding.
    Gómez R, Navarro M, Ferrer B, Trigo JM, Bilbao A, Del Arco I, Cippitelli A, Nava F, Piomelli D, Rodríguez de Fonseca F.
    J Neurosci; 2002 Nov 01; 22(21):9612-7. PubMed ID: 12417686
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Anandamide, a natural ligand for the peripheral cannabinoid receptor is a novel synergistic growth factor for hematopoietic cells.
    Valk P, Verbakel S, Vankan Y, Hol S, Mancham S, Ploemacher R, Mayen A, Löwenberg B, Delwel R.
    Blood; 1997 Aug 15; 90(4):1448-57. PubMed ID: 9269762
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Isolation and measurement of the endogenous cannabinoid receptor agonist, anandamide, in brain and peripheral tissues of human and rat.
    Felder CC, Nielsen A, Briley EM, Palkovits M, Priller J, Axelrod J, Nguyen DN, Richardson JM, Riggin RM, Koppel GA, Paul SM, Becker GW.
    FEBS Lett; 1996 Sep 16; 393(2-3):231-5. PubMed ID: 8814296
    [Abstract] [Full Text] [Related]

  • 28. Effects of cannabinoid receptor ligands on LPS-induced pulmonary inflammation in mice.
    Berdyshev E, Boichot E, Corbel M, Germain N, Lagente V.
    Life Sci; 1998 Sep 16; 63(8):PL125-9. PubMed ID: 9718090
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Inhibitory effects of cannabinoid receptor ligands on electrically-evoked responses in rat isolated tracheal ring segments.
    Yousif MH, Oriowo MA.
    Pharmacol Res; 1999 Nov 16; 40(5):415-21. PubMed ID: 10527656
    [Abstract] [Full Text] [Related]

  • 31. Probable involvement of Ca(2+)-activated Cl(-) channels (CaCCs) in the activation of CB1 cannabinoid receptors.
    Romero TR, Pacheco Dda F, Duarte ID.
    Life Sci; 2013 May 02; 92(14-16):815-20. PubMed ID: 23123446
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Human mast cells take up and hydrolyze anandamide under the control of 5-lipoxygenase and do not express cannabinoid receptors.
    Maccarrone M, Fiorucci L, Erba F, Bari M, Finazzi-Agrò A, Ascoli F.
    FEBS Lett; 2000 Feb 25; 468(2-3):176-80. PubMed ID: 10692582
    [Abstract] [Full Text] [Related]

  • 37. Inhibition of nitric oxide production in RAW264.7 macrophages by cannabinoids and palmitoylethanolamide.
    Ross RA, Brockie HC, Pertwee RG.
    Eur J Pharmacol; 2000 Aug 04; 401(2):121-30. PubMed ID: 10924916
    [Abstract] [Full Text] [Related]

  • 38. Palmitoylethanolamide inhibits the expression of fatty acid amide hydrolase and enhances the anti-proliferative effect of anandamide in human breast cancer cells.
    Di Marzo V, Melck D, Orlando P, Bisogno T, Zagoory O, Bifulco M, Vogel Z, De Petrocellis L.
    Biochem J; 2001 Aug 15; 358(Pt 1):249-55. PubMed ID: 11485574
    [Abstract] [Full Text] [Related]

  • 39. Cannabinoid CB1 receptor of cat cerebral arterial muscle functions to inhibit L-type Ca2+ channel current.
    Gebremedhin D, Lange AR, Campbell WB, Hillard CJ, Harder DR.
    Am J Physiol; 1999 Jun 15; 276(6):H2085-93. PubMed ID: 10362691
    [Abstract] [Full Text] [Related]

  • 40. Characterization of a novel endocannabinoid, virodhamine, with antagonist activity at the CB1 receptor.
    Porter AC, Sauer JM, Knierman MD, Becker GW, Berna MJ, Bao J, Nomikos GG, Carter P, Bymaster FP, Leese AB, Felder CC.
    J Pharmacol Exp Ther; 2002 Jun 15; 301(3):1020-4. PubMed ID: 12023533
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.